ArticleCurrent neuropharmacology2022

Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint.

Marika Alborghetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.